Company Introduction

Company introduction

R&D Pipeline
GeneOne Life
Science, Inc.

GeneOne Life Science, Inc. is a biopharmaceutical

R&D company dedicated to the development
and contract manufacturing of plasmid-based
biomedicines, including DNA vaccines.

With exclusive rights to use core technologies of DNA design and in

vivo delivery that are critical in development of gene-based biomedi-
cines – including DNA vaccines – GeneOne Life Science, Inc. is distin-
guished from most global competitors that use partial technologies.
The company is recognized as a global leading company in this field
with advanced technologies and patents in manufacturing of DNA
vaccines and plasmid medicines and wholly owns an international-
ly-recognized plasmid contract manufacturing organization (CMO)
called VGXI, Inc. that satisfies international standards for clinical
pharmaceutical products.
CEO
Young K. Park
Location
223 Teheran-Ro, Suite 1903,
Gangnam-Gu, Seoul, Korea
Homepage
www.genels.com
Homepage
Moonsup JEONG (Director/
Pharma R&D Division),
(msjeong@genels.com,
+82-2-557-6784)

28 29